| 摘要: |
| 复方双层片剂可通过联合用药或调整释药速率的方式来增强药效、减轻药物的不良反应、提高患者依从性,是固体制剂领域广受关注的新型制剂。本文结合文献专利、国内外药品相关法律法规和指导原则,对化学仿制药复方双层片在处方筛选和工艺开发过程中的关注点进行总结,包括原料药的粉体学性质、辅料筛选、多规格处方设计、双层压片工艺的开发和批量放大等,以期对化学仿制药复方双层片的开发提供一定的参考。 |
| 关键词: 复方双层片 粒径分布 处方工艺开发 |
| DOI:10.13506/j.cnki.jpr.2026.02.010 |
| 基金项目: |
|
出版日期:2026-02-25
|
|
| General considerations for the prescription and process developmentof chemical generic compound bilayer tablets |
| LYU Yaping,ZHAO Na,SUN Yuanpeng,XIE Yan,ZHANG Junlin |
| (Center for Drug Evaluation, National Medical Products Administration, Beijing 100076, China) |
| Abstract: |
| Compound bilayer tablets have been widely concerned in the development of novel solid formulations because of its advantages including enhancing drug efficacy, reducing side effects and improving patient compliance by combining medications or adjusting the rate of drug release. This review summarizes the key points in prescription screening and process development of chemical generic compound bilayer tablets, combining the literature patents, relevant domestic and foreign drug laws and regulations. This includes the characteristics of active pharmaceutical ingredients, the selection of excipients, the design of multi-strengths prescription, the development of bi-layer process and batch amplification, etc., in order to provide a reference for generic compound bilayer tablets drug development. |
| Key words: Compound bilayer tablets Particle size distribution Prescription and process development |